Novateor Research Laboratories Limited has announced a significant change in its key managerial personnel. The company has appointed Mrs. Pooja Bafna Rathi as its new Company Secretary cum Compliance Officer, effective November 3, 2025.

Key Details of the Appointment

Professional Background

Mrs. Rathi brings a diverse educational background to her new role:

• Associate Company Secretary (ACS)
• UGC-NET qualified
• Bachelor of Laws (LLB)
• Bachelor of Education (B.Ed)
• Central Teacher Eligibility Test (CTET) qualified
• Master of Commerce in Business Policy and Corporate Governance [M.Com (BP&CG)]

This appointment is in compliance with Section 203 of the Companies Act, 2013, and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Implications for Novateor Research Laboratories

The appointment of Mrs. Rathi as Company Secretary and Compliance Officer is a crucial move for Novateor Research Laboratories Limited. In this role, she will be responsible for ensuring the company's adherence to regulatory requirements and maintaining effective corporate governance practices.

It's worth noting that as of the appointment date, Mrs. Rathi holds no shares in the company, as disclosed in the official communication.

This strategic appointment underscores Novateor Research Laboratories' commitment to maintaining strong corporate governance and regulatory compliance. Mrs. Rathi's diverse qualifications and expertise are expected to contribute significantly to the company's administrative and compliance functions.

Novateor Research Laboratories Limited , a company listed on the Bombay Stock Exchange (BSE: 542771), is seeking shareholder approval to diversify its business operations. The company has proposed amendments to its Memorandum of Association (MOA) to include new business activities in dental equipment trading and chemicals trading.

Proposed Business Expansion

Dental Equipment Trading

Novateor plans to enter the dental equipment market with a comprehensive approach. The proposed activities include:

• Importing, exporting, distributing, and dealing in dental equipment, instruments, devices, and consumables
• Handling digital and diagnostic tools for dental applications
• Acting as representatives or distributors for domestic and foreign manufacturers in the dental and allied healthcare products sector

Chemicals Trading

The company also aims to venture into the chemicals sector with the following activities:

• Trading, importing, exporting, and distributing various chemicals, paints, coatings, emulsions, varnishes, resins, adhesives, and solvents
• Formulating, blending, mixing, and packaging chemical products
• Providing painting, coating, waterproofing, and protective treatment services for industrial, commercial, and residential premises

Corporate Governance and Compliance

The proposed expansion requires restructuring the Objects clause of the company's MOA, subject to appropriate regulatory approvals. Novateor has taken steps to ensure compliance with regulatory requirements:

1. The company held its 14th Annual General Meeting (AGM) on September 30, where the proposed amendments were presented as a special resolution.

2. Mr. Anil Tilakraj Arora (DIN: 03469947) has been appointed as a Non-Executive Independent Director for a term of five years, effective September 3. Mr. Arora brings over 40 years of experience as a dental practitioner and entrepreneur, which aligns with the company's proposed expansion into the dental sector.

3. The company has announced the closure of its trading window for insiders from October 1, until 48 hours after the announcement of the financial results for the half-year ending September 30, in compliance with SEBI regulations.

Management Commentary

Navdeep Mehta, Managing Director of Novateor Research Laboratories Limited, stated, "The proposed expansion into dental equipment and chemicals trading represents a strategic move to diversify our business portfolio. We believe these new ventures will complement our existing operations and create new growth opportunities for the company."

The outcome of the shareholder vote on these proposed amendments will be crucial in determining the future direction of Novateor Research Laboratories Limited. Investors and stakeholders are advised to monitor further announcements from the company regarding the results of the AGM and the implementation of these proposed changes.